← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2009Last known activity
May 17, 2018
Timeline
2000s
- Jan 1, 2008
Venn Life Sciences— Founded
2010s
- Oct 19, 2010
DCI France— Acquired
- Nov 5, 2013
CRM Biometrics GmbH— Acquired
- Dec 9, 2013
Medevol— Acquired
- Aug 11, 2014
Cardinal Systems SAS— Acquired
- Oct 1, 2015
Kinesis Pharma— Acquired
Drugs by trial phase (16 distinct, 15 trials)
Phase 3 (4 own, 1 via acquisition)
Phase 2 (3 own, 1 via acquisition)
Phase 1 (2 own, 3 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Subsidiaries (5 direct, 5 total across the full acquisition tree)
Recent trials (6)
- NCT03634085CollaboratorPhase 1May 17, 2018
- NCT02515656CollaboratorPhase 3Sep 1, 2015
- NCT02303717CollaboratorN/ADec 1, 2014
- NCT03300453CollaboratorPhase 1/Phase 2Sep 30, 2013
- NCT00864110CollaboratorPhase 1Apr 1, 2010
- NCT00865319CollaboratorPhase 2Jun 1, 2009
Details
- Founded
- Dublin, IE Jan 1, 2008
- Last known activity
- May 17, 2018